No connection

Search Results

FCRX

BEARISH
$25.03 Live
Crescent Capital BDC, Inc. · NYSE
$24.5 52W Range $25.24

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 27, 2026
Market cap
N/A
P/E
176.27
ROE
4.8%
Profit margin
20.6%
Debt/Equity
1.24
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
95%
FCRX exhibits a stable Piotroski F-Score of 5/9, but this is overshadowed by a catastrophic valuation disconnect where the current price of $25.03 vastly exceeds the Graham Number ($7.81) and the Intrinsic Value ($0.99). The company is experiencing negative growth across both revenue (-12.10%) and earnings (-14.90%), while trading at an unsustainable P/E ratio of 176.27. Despite a stable health score, the combination of bearish technicals, declining fundamentals, and extreme overvaluation suggests significant downside risk.

Key Strengths

Stable Piotroski F-Score (5/9)
Positive long-term price performance (5Y Change +22.6%)
Strong operating margin (75.36%)
Price/Book ratio (1.31) is relatively modest compared to the P/E
Current ratio (1.27) indicates basic short-term solvency

Key Risks

Extreme valuation gap (Price $25.03 vs Intrinsic Value $0.99)
Negative YoY revenue growth (-12.10%)
Negative YoY earnings growth (-14.90%)
Unsustainable P/E ratio of 176.27
Poor liquidity indicated by a Quick Ratio of 0.56
AI Fair Value Estimate
Based on comprehensive analysis
$7.81
-68.8% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
29
Weak
Value
10
Future
20
Past
60
Health
55
Dividend
0
AI Verdict
Severely Overvalued
Key drivers: Extreme P/E ratio, Negative growth trends, Massive divergence from intrinsic value
Confidence
90%
Value
10/100

Ref P/E 176.27, Graham Number $7.81, Intrinsic Value $0.99

Positives
  • P/B ratio is not excessively high
Watchpoints
  • P/E of 176.27
  • Price is >3x the Graham Number
  • Price is >25x the Intrinsic Value
Future
20/100

Ref Growth rates

Positives
No standout positives identified.
Watchpoints
  • Revenue growth -12.10%
  • Earnings growth -14.90%
  • Q/Q earnings growth -15.00%
Past
60/100

Ref Historical trends

Positives
  • Positive 1Y, 3Y, and 5Y price changes
Watchpoints
  • Recent 1M change is negative
Health
55/100

Ref Piotroski F-Score

Positives
  • Piotroski F-Score 5/9 (Stable)
Watchpoints
  • Quick Ratio 0.56
  • Debt/Equity 1.24
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • Dividend strength 0/100
  • No yield reported

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$25.03

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for FCRX and closest competitors.

Updated 2026-04-24
FCR
Crescent Capital BDC, Inc.
Primary
5Y
+22.6%
3Y
+20.7%
1Y
+6.6%
6M
+2.7%
1M
-0.1%
1W
+0.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
176.27
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
1.31
P/S Ratio
N/A
EV/Revenue
10.72
EV/EBITDA
N/A
Market Cap
N/A

Profitability

Profit margins and return metrics

Profit Margin 20.63%
Operating Margin 75.36%
Gross Margin 100.0%
ROE 4.77%
ROA 4.81%

Growth

Revenue and earnings growth rates

Revenue Growth -12.1%
Earnings Growth -14.9%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth -15.0%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
1.24
Moderate
Current Ratio
1.27
Good
Quick Ratio
0.56
Poor
Cash/Share
$0.14

Ownership Structure

Institutional and insider holdings breakdown

Ownership Breakdown

Top Institutional Holders

Karpus Management, Inc.
317,674 shares • 2025-12-31

SEC Filings

Recent regulatory filings from the SEC EDGAR database

DEF 14A
DEF 14A
2026-04-01

FCRX filed a definitive proxy statement on April 1, 2026, providing shareholders with necessary information and voting materials for an upcoming meeting.

8-K
8-K
2026-03-09
10-K
10-K
2026-02-25

FCRX filed its annual 10-K report on February 25, 2026. The provided excerpts do not contain specific financial metrics or detailed risk disclosures for analysis.

8-K
8-K
2026-02-25

FCRX filed an 8-K on February 25, 2026, likely to announce its fourth-quarter and full-year financial results.

8-K
8-K
2025-11-12
10-Q
10-Q
2025-11-12

FCRX submitted its 10-Q filing on November 12, 2025. While the document includes a section for Risk Factors under Item 1A, no specific financial highlights or detailed risk disclosures were provided in the available excerpt.

8-K
8-K
2025-11-03

FCRX filed a Form 8-K on November 3, 2025, likely to announce its third-quarter financial results.

8-K
8-K
2025-08-13

FCRX filed an 8-K on August 13, 2025, likely to announce its second-quarter financial results.

10-Q
10-Q
2025-08-13

FCRX filed its 10-Q on August 13, 2025, which includes a section dedicated to Risk Factors. No specific financial highlights or detailed risk descriptions were provided in the available excerpt.

8-K
8-K
2025-05-19
8-K
8-K
2025-05-14
10-Q
10-Q
2025-05-14
8-K
8-K
2025-04-15
DEF 14A
CRESCENT CAPITAL BDC (CCAP) - DEF 14A
2025-03-28
8-K
8-K
2025-02-19
Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning FCRX from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile